| Control Group | Treatment Group |
Number of patients | 30 | 32 |
Age, years | 62 ± 7 | 62 ± 7 |
Sex (male/female) | 10/20 | 10/22 |
Duration of symptoms prior to presentation, months | 2.5 ± 1.9 | 3.0 ± 1.4 |
BCVA, letters | 65 ± 13 | 64 ± 14 |
CRT, μm | 385.3 ± 8.3 | 406.3 ± 23.3 |
RCT, sec | 5.15 ± 0.21 | 5.11 ± 0.29 |